Home

Beryl Drugs Ltd Quarterly Result

Image

Beryl Drugs Ltd

NSE: BERYLDRUGS

Net Profit - Last Quarter

₹ 0.05 Cr.

Last updated on: May 12, 2025

Beryl Drugs Ltd Quarterly Results Key Highlights

  • The revenue of Beryl Drugs Ltd for the Dec '24 is ₹ 5.4 crore as compare to the Sep '24 revenue of ₹ 5.65 crore.
  • This represent the decline of -4.42%a1# The ebitda of Beryl Drugs Ltd for the Dec '24 is ₹ 0.59 crore as compare to the Sep '24 ebitda of ₹ 0.57 crore.
  • This represent the growth of 3.51%a1# The net profit of Beryl Drugs Ltd for the Dec '24 is ₹ 0.05 crore as compare to the Sep '24 net profit of ₹ 0.01 crore.
  • This represent the growth of 400%a1#.

Beryl Drugs Ltd Quarterly Results Analysis

Market Price of Beryl Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beryl Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
09 May 202517.48
08 May 202518.2
07 May 202518.63
06 May 202519.59
05 May 202519.99
02 May 202519.55
30 Apr 202520.29
29 Apr 202521.12
28 Apr 202522.2
25 Apr 202522.83

Historical Revenue of Beryl Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Beryl Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beryl Drugs Ltd

No data available

* All values are in crore

Beryl Drugs Ltd News Hub

Beryl Drugs standalone net profit declines 30.19% in the June 2024 quarter

Net profit of Beryl Drugs declined 30.19% to Rs 0.37 crore in the quarter ended June 2024 as against

Read more

09 Aug 24

Beryl Drugs to conduct board meeting

Beryl Drugs will hold a meeting of the Board of Directors of the Company on 3 September 2024. Powere

Read more

27 Aug 24

Beryl Drugs to hold AGM

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 Septem

Read more

11 Sept 24

Beryl Drugs to convene AGM

Beryl Drugs announced that the Annual General Meeting (AGM) of the company will be held on 30 Septem

Read more

11 Sept 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Beryl Drugs Ltd

What key financial metrics are included in Beryl Drugs Ltd's quarterly results?

Key financial metrics in Beryl Drugs Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Beryl Drugs Ltd announce its quarterly results?

Beryl Drugs Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Beryl Drugs Ltd's quarterly performance impact its stock price?

Beryl Drugs Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Beryl Drugs Ltd's quarterly results on dividends?

The impact of Beryl Drugs Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Beryl Drugs Ltd's quarterly results?

Yes, Beryl Drugs Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions